Literature DB >> 11222694

Macrophage tropism of human immunodeficiency virus type 1 facilitates in vivo escape from cytotoxic T-lymphocyte pressure.

M Schutten1, C A van Baalen, C Guillon, R C Huisman, P H Boers, K Sintnicolaas, R A Gruters, A D Osterhaus.   

Abstract

Early after seroconversion, macrophage-tropic human immunodeficiency virus type 1 (HIV-1) variants are predominantly found, even when a mixture of macrophage-tropic and non-macrophage-tropic variants was transmitted. For virus contracted by sexual transmission, this is presently explained by selection at the port of entry, where macrophages are infected and T cells are relatively rare. Here we explore an additional mechanism to explain the selection of macrophage-tropic variants in cases where the mucosa is bypassed during transmission, such as blood transfusion, needle-stick accidents, or intravenous drug abuse. With molecularly cloned primary isolates of HIV-1 in irradiated mice that had been reconstituted with a high dose of human peripheral blood mononuclear cells, we found that a macrophage-tropic HIV-1 clone escaped more efficiently from specific cytotoxic T-lymphocyte (CTL) pressure than its non-macrophage-tropic counterpart. We propose that CTLs favor the selective outgrowth of macrophage-tropic HIV-1 variants because infected macrophages are less susceptible to CTL activity than infected T cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222694      PMCID: PMC115895          DOI: 10.1128/JVI.75.6.2706-2709.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

Review 1.  The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28.

Authors:  K Tanaka; M Kasahara
Journal:  Immunol Rev       Date:  1998-06       Impact factor: 12.988

2.  Broadening of coreceptor usage by human immunodeficiency virus type 2 does not correlate with increased pathogenicity in an in vivo model.

Authors:  M E van Der Ende; C Guillon; P H Boers; R A Gruters; P Racz; K Tenner-Racz; A D Osterhaus; M Schutten
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

3.  Early replication steps but not cell type-specific signalling of the viral long terminal repeat determine HIV-1 monocytotropism.

Authors:  H Schuitemaker; M Groenink; L Meyaard; N A Kootstra; R A Fouchier; R A Gruters; H G Huisman; M Tersmette; F Miedema
Journal:  AIDS Res Hum Retroviruses       Date:  1993-07       Impact factor: 2.205

4.  Phenotypic heterogeneity in a panel of infectious molecular human immunodeficiency virus type 1 clones derived from a single individual.

Authors:  M Groenink; R A Fouchier; R E de Goede; F de Wolf; R A Gruters; H T Cuypers; H G Huisman; M Tersmette
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Selective in vitro expansion of HLA class I-restricted HIV-1 Gag-specific CD8+ T cells: cytotoxic T-lymphocyte epitopes and precursor frequencies.

Authors:  C A van Baalen; M R Klein; A M Geretti; R I Keet; F Miedema; C A van Els; A D Osterhaus
Journal:  AIDS       Date:  1993-06       Impact factor: 4.177

6.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.

Authors:  R A Koup; J T Safrit; Y Cao; C A Andrews; G McLeod; W Borkowsky; C Farthing; D D Ho
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

7.  Genotypic and phenotypic characterization of HIV-1 patients with primary infection.

Authors:  T Zhu; H Mo; N Wang; D S Nam; Y Cao; R A Koup; D D Ho
Journal:  Science       Date:  1993-08-27       Impact factor: 47.728

8.  Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection.

Authors:  M T Roos; J M Lange; R E de Goede; R A Coutinho; P T Schellekens; F Miedema; M Tersmette
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

9.  Acute human vs. mouse graft vs. host disease in normal and immunodeficient mice.

Authors:  W Huppes; B De Geus; C Zurcher; D W Van Bekkum
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

10.  Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

Authors:  H Schuitemaker; M Koot; N A Kootstra; M W Dercksen; R E de Goede; R P van Steenwijk; J M Lange; J K Schattenkerk; F Miedema; M Tersmette
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more
  7 in total

1.  CD8+ T cell-mediated CXC chemokine receptor 4-simian/human immunodeficiency virus suppression in dually infected rhesus macaques.

Authors:  Janet M Harouse; Clarisa Buckner; Agegnehu Gettie; Ross Fuller; Rudolf Bohm; James Blanchard; Cecilia Cheng-Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

2.  Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals.

Authors:  M Kearney; F Maldarelli; W Shao; J B Margolick; E S Daar; J W Mellors; V Rao; J M Coffin; S Palmer
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

3.  Restricted SIV replication in rhesus macaque lung tissues during the acute phase of infection.

Authors:  Craig L Fuller; Yang K Choi; Beth A Fallert; Saverio Capuano; Premeela Rajakumar; Michael Murphey-Corb; Todd A Reinhart
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

4.  Gamma interferon/interleukin 10 balance in tissue lymphocytes correlates with down modulation of mucosal feline immunodeficiency virus infection.

Authors:  Paul R Avery; Edward A Hoover
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 5.  Selective transmission of R5 HIV-1 variants: where is the gatekeeper?

Authors:  Jean-Charles Grivel; Robin J Shattock; Leonid B Margolis
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

6.  The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIVSF162P3N infection.

Authors:  Lily Tsai; Ivan Tasovski; Ana Rachel Leda; Mario P S Chin; Cecilia Cheng-Mayer
Journal:  Retrovirology       Date:  2014-03-11       Impact factor: 4.602

7.  Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIVSF162P3N molecular clones in rhesus macaques.

Authors:  Wuze Ren; Alexandra Mumbauer; Ke Zhuang; Carole Harbison; Heather Knight; Susan Westmoreland; Agegnehu Gettie; James Blanchard; Cecilia Cheng-Mayer
Journal:  Retrovirology       Date:  2013-01-31       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.